Literature DB >> 26943182

Recent trends in the prevalence of chronic kidney disease in Korean adults: Korean National Health and Nutrition Examination Survey from 1998 to 2013.

Hyun-Young Shin1,2, Hee-Taik Kang3.   

Abstract

BACKGROUND: Chronic kidney disease (CKD) is associated with aging, diabetes, hypertension, dyslipidemia, obesity, and unhealthy lifestyle behaviors and has become a public health burden worldwide.
METHODS: We investigated the trends of CKD prevalence over a period of 16 years in Korean adults based on the Korean National Health and Nutrition Examination Survey (KNHANES): phase I (1998), II (2001), III (2005), IV (2007-09), V (2010-2012), and VI (2013). Of the 105,504 individuals aged over 20 years who participated in KNHANES I-VI, 55,191 (23,729 men and 31,462 women) were included in the present study.
RESULTS: The sequential percentage of glomerular filtration rate (GFR) <60 ml/min/1.73 m2 in KNHANES I-VI was 1.0, 4.2, 3.2, 1.9, 1.6, and 2.1 % in men and 3.6, 9.3, 10.4, 3.1, 1.6, and 2.0 % in women, respectively. The percentage of proteinuria ≥1+ in men rebounded after KNHANES V (3.1, 2.9, 2.8, 1.9, 1.1, and 1.7 % in KNHANES I-VI, respectively), but in women declined across all KNHANES reads (3.4, 2.3, 1.4, 1.6, 1.0, and 0.9 %, respectively). The prevalence of CKD rebounded after KNHANES V for men (3.9, 6.8, 5.5, 3.5, 2.4, and 3.5 % in KNHANES I-VI) while those in women decreased to a plateau level (6.6, 10.9, 11.4, 4.2, 2.4, and 2.4 % in KNHANES I-VI, respectively).
CONCLUSIONS: Our study shows that the prevalence of CKD in Korean adults has decreased overall, but since KNHANES V there has been a rebound in men while no changes in women.

Entities:  

Keywords:  Chronic kidney disease; Glomerular filtration rate; Obesity; Prevalence; Proteinuria

Mesh:

Year:  2016        PMID: 26943182     DOI: 10.1007/s40620-016-0280-y

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  28 in total

1.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

2.  Trends in estimated kidney function: the FINRISK surveys.

Authors:  Auni Juutilainen; Helena Kastarinen; Riitta Antikainen; Markku Peltonen; Veikko Salomaa; Jaakko Tuomilehto; Pekka Jousilahti; Jouko Sundvall; Tiina Laatikainen; Mika Kastarinen
Journal:  Eur J Epidemiol       Date:  2012-04       Impact factor: 8.082

3.  The effects of rosiglitazone and metformin on inflammation and endothelial dysfunction in patients with type 2 diabetes mellitus.

Authors:  Evren Fidan; H Onder Ersoz; Mustafa Yilmaz; Hulya Yilmaz; Mustafa Kocak; Caner Karahan; Cihangir Erem
Journal:  Acta Diabetol       Date:  2011-03-23       Impact factor: 4.280

4.  Trends in the prevalence of chronic kidney disease, other chronic diseases and health-related behaviors in an adult Korean population: data from the Korean National Health and Nutrition Examination Survey (KNHANES).

Authors:  Seong Woo Lee; Yong Chul Kim; Se-Won Oh; Ho Seok Koo; Ki Young Na; Dong-Wan Chae; Suhnggwon Kim; Ho Jun Chin
Journal:  Nephrol Dial Transplant       Date:  2011-03-31       Impact factor: 5.992

5.  A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group.

Authors:  A S Levey; J P Bosch; J B Lewis; T Greene; N Rogers; D Roth
Journal:  Ann Intern Med       Date:  1999-03-16       Impact factor: 25.391

6.  Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes.

Authors:  A S Levey; R Atkins; J Coresh; E P Cohen; A J Collins; K-U Eckardt; M E Nahas; B L Jaber; M Jadoul; A Levin; N R Powe; J Rossert; D C Wheeler; N Lameire; G Eknoyan
Journal:  Kidney Int       Date:  2007-06-13       Impact factor: 10.612

7.  Prevalence of chronic kidney disease in a representative sample of the Polish population: results of the NATPOL 2011 survey.

Authors:  Łukasz Zdrojewski; Tomasz Zdrojewski; Marcin Rutkowski; Piotr Bandosz; Ewa Król; Bogdan Wyrzykowski; Bolesław Rutkowski
Journal:  Nephrol Dial Transplant       Date:  2015-11-10       Impact factor: 5.992

8.  Prevalence estimates of chronic kidney disease in Canada: results of a nationally representative survey.

Authors:  Paul Arora; Priya Vasa; Darren Brenner; Karl Iglar; Phil McFarlane; Howard Morrison; Alaa Badawi
Journal:  CMAJ       Date:  2013-05-06       Impact factor: 8.262

9.  Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.

Authors: 
Journal:  Lancet       Date:  2014-12-18       Impact factor: 79.321

Review 10.  The link between chronic kidney disease and cardiovascular disease.

Authors:  Sarmad Said; German T Hernandez
Journal:  J Nephropathol       Date:  2014-07-01
View more
  11 in total

Review 1.  Therapeutic potential of microRNAs for the treatment of renal fibrosis and CKD.

Authors:  Wenshan Lv; Fan Fan; Yangang Wang; Ezekiel Gonzalez-Fernandez; Chen Wang; Lili Yang; George W Booz; Richard J Roman
Journal:  Physiol Genomics       Date:  2017-11-10       Impact factor: 3.107

Review 2.  Inflammation and renal fibrosis: Recent developments on key signaling molecules as potential therapeutic targets.

Authors:  Wenshan Lv; George W Booz; Yangang Wang; Fan Fan; Richard J Roman
Journal:  Eur J Pharmacol       Date:  2017-12-08       Impact factor: 4.432

Review 3.  Sex and gender disparities in the epidemiology and outcomes of chronic kidney disease.

Authors:  Juan Jesus Carrero; Manfred Hecking; Nicholas C Chesnaye; Kitty J Jager
Journal:  Nat Rev Nephrol       Date:  2018-01-22       Impact factor: 28.314

4.  Chronic kidney disease is more prevalent among women but more men than women are under nephrological care : Analysis from six outpatient clinics in Austria 2019.

Authors:  Michal J Lewandowski; Simon Krenn; Amelie Kurnikowski; Philipp Bretschneider; Martina Sattler; Elisabeth Schwaiger; Marlies Antlanger; Philipp Gauckler; Markus Pirklbauer; Maria Brunner; Sabine Horn; Emanuel Zitt; Bernhard Kirsch; Martin Windpessl; Manfred Wallner; Ida Aringer; Martin Wiesholzer; Manfred Hecking; Sebastian Hödlmoser
Journal:  Wien Klin Wochenschr       Date:  2022-08-31       Impact factor: 2.275

5.  Long noncoding RNA MANTIS relieved the protein-bound uremic toxin-induced injury on human umbilical vein endothelial cells in chronic kidney disease and end-stage renal disease.

Authors:  Jie Jiang; Dongwen Zheng; Yi Li; Guohui Liu; Hongmei Zhou; Yan Liu
Journal:  Int J Clin Exp Pathol       Date:  2018-07-01

6.  The Association between Socioeconomic Status and Adherence to Health Check-up in Korean Adults, Based on the 2010-2012 Korean National Health and Nutrition Examination Survey.

Authors:  Hyun-Young Shin; Hee-Taik Kang; Jae Woo Lee; Hyoung-Ji Lim
Journal:  Korean J Fam Med       Date:  2018-03-22

Review 7.  Oxidative Stress and Renal Fibrosis: Recent Insights for the Development of Novel Therapeutic Strategies.

Authors:  Wenshan Lv; George W Booz; Fan Fan; Yangang Wang; Richard J Roman
Journal:  Front Physiol       Date:  2018-02-16       Impact factor: 4.566

8.  Older menarche age and short reproductive period linked to chronic kidney disease risk.

Authors:  Ji Hyun Noh; Hoseok Koo
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

9.  Epidemiology of chronic kidney disease in Peru and its relation to social determinants of health.

Authors:  Noé Atamari-Anahui; Maycol Suker Ccorahua-Rios; Mirian Condori-Huaraka; Yerika Huamanvilca-Yepez; Elard Amaya; Percy Herrera-Añazco
Journal:  Int Health       Date:  2020-07-01       Impact factor: 2.473

10.  Estimating disease prevalence from drug utilization data using the Random Forest algorithm.

Authors:  Laurentius C J Slobbe; Koen Füssenich; Albert Wong; Hendriek C Boshuizen; Markus M J Nielen; Johan J Polder; Talitha L Feenstra; Hans A M van Oers
Journal:  Eur J Public Health       Date:  2019-08-01       Impact factor: 3.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.